The Saratoga Large Cap Value Portfolio posted a slightly positive return for the fourth quarter of 2017. The Portfolio’s performance in the quarter was hampered by weakness in its Healthcare stocks, somewhat offset by strength in Financials and Industrials. US equities at large have been posting record highs, supported by broadening synchronized global economic growth, benign inflation and bond yields, and the future possible benefits from corporate tax reform in the US. We continue to believe that fundamental value investing has great potential. While 2016 and 2017 were challenging for value investing, as many investors chased momentum and growth stocks, we think it is likely that when general market conditions become less favorable and the most popular, crowded high-momentum equities are potentially pressured by a rush for liquidity, that out of favor, contrarian value stocks are likely to outperform.
Information contained herein was obtained from recognized statistical services and other sources believed to be reliable and we therefore cannot make any representation as to its completeness or accuracy. Any statements not of a factual nature constitute opinions which are subject to change without notice.
Investors should carefully consider the investment objectives, risks, charges and expenses of the Saratoga Advantage Trust mutual funds. This and other important information about the Saratoga Advantage Trust's funds is contained in the prospectus, which can be obtained by clicking here, or by calling (800) 807-FUND, and which should be read carefully before investing. The Saratoga Advantage Trust's funds are distributed by Northern Lights Distributors, LLC, member FINRA/SIPC. Saratoga Capital Management, LLC is not affiliated with Northern Lights Distributors, LLC. 1/16 © Saratoga Capital Management, LLC; All Rights Reserved.